Kurv Yield Prem Strategy Tesla ETF (TSLP)
| Assets | $15.99M |
| Expense Ratio | 1.00% |
| PE Ratio | 120.49 |
| Forward PE | n/a |
| Shares Out | 1.07M |
| Dividend | $4.60 (29.31%) |
| Ex-Dividend Date | Nov 4, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 3,115 |
| Open | 15.49 |
| Previous Close | 15.38 |
| Day's Range | 15.38 - 15.80 |
| 52-Week Low | 12.92 |
| 52-Week High | 26.32 |
| Beta | 1.29 |
| Holdings | 12 |
| Inception Date | Oct 27, 2023 |
About TSLP
Fund Home PageThe Kurv Yield Prem Strategy Tesla ETF (TSLP) is an exchange-traded fund that mostly invests in consumer discretionary stocks. The fund seeks to provide current income and capped gains on the Tesla stock (TSLA) through a synthetic covered call strategy, collateralized by cash and short-term fixed-income instruments. The actively managed fund uses both standardized exchange-traded and FLEX options. TSLP was launched on Oct 27, 2023 and is issued by Kurv.
Top 10 Holdings
117.65% of assets| Name | Symbol | Weight |
|---|---|---|
| United States Treasury Bills 0% | B.0 03.18.27 | 36.44% |
| United States Treasury Bills 0% | B.0 12.24.26 | 27.76% |
| Tsla 12/18/2026 350 C | n/a | 22.67% |
| United States Treasury Bills 0% | B.0 06.10.27 | 17.74% |
| Tsla 12/18/2026 210 C | n/a | 12.12% |
| Tsla 12/18/2026 330 P | n/a | 0.65% |
| Fidelity Inv MM Government I | FIGXX | 0.63% |
| OTHER ASSETS AND LIABILITIES | n/a | -0.01% |
| Tsla 11/13/2026 430 C | n/a | -0.08% |
| Tsla 11/20/2026 395 C | n/a | -0.28% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Nov 4, 2026 | $0.320 | Nov 5, 2026 |
| Oct 7, 2026 | $0.320 | Oct 8, 2026 |
| Sep 2, 2026 | $0.320 | Sep 3, 2026 |
| Aug 5, 2026 | $0.320 | Aug 6, 2026 |
| Jul 8, 2026 | $0.320 | Jul 9, 2026 |
| Jun 3, 2026 | $0.350 | Jun 4, 2026 |
Performance
TSLP had a total return of -16.69% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.60%.
News
Kurv Investment Management Completes Reorganization of Yield Premium Suite to Proprietary Trust
SAN FRANCISCO--(BUSINESS WIRE)--Kurv Investment Management, an ETF provider of tax-efficient, institutional-grade investment strategies, announces the successful reorganization of its Yield Premium Su...
AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Soci...